acquired
Stage
2000
Founded
1
Investors
About
Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its proprietary Arcelis technology platform.
Explore Argos Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.